Skip to content
10-Q

Quarterly Report

KalVista Pharmaceuticals, Inc. KALV

0001193125-25-274442

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 50.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 53.88M sh
Shares Diluted Q3 2025 · Sep 30, 2025 53.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.59M sh
Shares Diluted Q3 2025 · Sep 30, 2024 44.17M sh
Capex Q3 2025 · Sep 30, 2025 $1.86M
Capex Q3 2025 · Sep 30, 2024 $53K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$126.99M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$91.65M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $243.5M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $182.33M
Stockholders Equity Q3 2025 · Sep 30, 2025 $17M
Stockholders Equity Q3 2025 · Jun 30, 2025 $59.45M
Stockholders Equity Q3 2025 · Mar 31, 2025 $116.76M
Stockholders Equity Q3 2025 · Dec 31, 2024 $164.36M
Stockholders Equity Q3 2025 · Sep 30, 2024 $148.53M
Stockholders Equity Q3 2025 · Jun 30, 2024 $180.93M
Stockholders Equity Q3 2025 · Mar 31, 2024 $217.6M
Stockholders Equity Q3 2025 · Dec 31, 2023 $97.87M
Current Liabilities Q3 2025 · Sep 30, 2025 $45.07M
Current Liabilities Q3 2025 · Dec 31, 2024 $26.11M
Total Liabilities Q3 2025 · Sep 30, 2025 $322.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $130.46M
Current Assets Q3 2025 · Sep 30, 2025 $325.23M
Current Assets Q3 2025 · Dec 31, 2024 $285.98M
Total Assets Q3 2025 · Sep 30, 2025 $339.93M
Total Assets Q3 2025 · Dec 31, 2024 $294.82M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.92
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.97
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.84
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.77
Eps Basic Q3 2025 · Sep 30, 2025 −$0.92
Eps Basic Q3 2025 · Sep 30, 2025 −$2.97
Eps Basic Q3 2025 · Sep 30, 2024 −$0.84
Eps Basic Q3 2025 · Sep 30, 2024 −$2.77
Sga Expense Q3 2025 · Sep 30, 2025 $46.52M
Sga Expense Q3 2025 · Sep 30, 2025 $126M
Sga Expense Q3 2025 · Sep 30, 2024 $24.8M
Sga Expense Q3 2025 · Sep 30, 2024 $63.51M
Rd Expense Q3 2025 · Sep 30, 2025 $11.99M
Rd Expense Q3 2025 · Sep 30, 2025 $41.21M
Rd Expense Q3 2025 · Sep 30, 2024 $18.68M
Rd Expense Q3 2025 · Sep 30, 2024 $70.17M
Net Income Q3 2025 · Sep 30, 2025 −$49.48M
Net Income Q3 2025 · Sep 30, 2025 −$158.91M
Net Income Q3 2025 · Jun 30, 2025 −$57.6M
Net Income Q3 2025 · Mar 31, 2025 −$51.84M
Net Income Q3 2025 · Sep 30, 2024 −$39.08M
Net Income Q3 2025 · Sep 30, 2024 −$122.53M
Net Income Q3 2025 · Jun 30, 2024 −$40.34M
Net Income Q3 2025 · Mar 31, 2024 −$43.11M
Operating Income Q3 2025 · Sep 30, 2025 −$46.05M
Operating Income Q3 2025 · Sep 30, 2025 −$154.74M
Operating Income Q3 2025 · Sep 30, 2024 −$43.48M
Operating Income Q3 2025 · Sep 30, 2024 −$133.68M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.23M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.23M
Revenue Q3 2025 · Sep 30, 2025 $13.69M
Revenue Q3 2025 · Sep 30, 2025 $13.69M